Pumping the brakes on autoimmune disease
A new study from researchers at Sanford Burnham Prebys and Eli Lilly and Company describes the science behind an autoimmune disease treatment in a Phase 2 clinical trial.
Source: eurekalert.org
Stay updated with breaking news from David Lippner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study from researchers at Sanford Burnham Prebys and Eli Lilly and Company describes the science behind an autoimmune disease treatment in a Phase 2 clinical trial.